Home  >  News
  US FDA accepts Medivir's IND application for MIV-711,   August 17, 2017
  Shuttle Pharma, POLA Pharma enter pact to license US rights for doranidazole,   August 16, 2017
  Ionis Pharma to advance inotersen and IONIS-FB-L Rx drugs independently,   August 14, 2017
  US FDA warns of potential contamination in multiple brands of drugs, dietary supplements,   August 14, 2017
  Wellcome Trust Sanger Institute chooses NEBNext reagents of New England Biolabs for RNA sequencing,   August 14, 2017
  Gilead Sciences receives US FDA priority review status for FDC bictegravir,   August 12, 2017
  BioreclamationIVT buys biospecimen & research services provider Asterand Bioscience,   August 12, 2017
  US FDA issues draft guidance on Child-Resistant Packaging, paediatrics calls for immediate adoption,   August 12, 2017
  Lipocine resubmits NDA for LPCN 1021 to treat hypogonadism,   August 11, 2017
  InDex Pharma's cobitolimod receives US FDA orphan-drug status to treat ulcerative colitis in pediatric patients,   August 11, 2017
  Tissue Regenix buys CellRight Technologies to expand US presence in regenerative medicine,   August 11, 2017
  Dermira obtains exclusive, worldwide rights to develop and commercialize lebrikizumab from Roche,   August 10, 2017
  US FDA grants orphan drug status to Ocugen's OCU300 to treat ocular graft versus host disease,   August 10, 2017
  Werum IT Solutions receives Asian Manufacturing Award in “Best Pharma Solutions Provider” category,   August 09, 2017
  Mylan's ARV fixed-dose combination TLD receives tentative approval from US FDA under PEPFAR,   August 09, 2017
  Endo reaches agreements to resolve virtually all known US mesh product liability claims,   August 09, 2017
  Bayer's Stivarga receives European approval for second-line systemic treatment of liver cancer,   August 09, 2017
  US Federal judge enters consent decree against outsourcing facility Isomeric Pharmacy Solutions,   August 08, 2017
  Perrigo receives US FDA tentative approval for generic Mirvaso gel,   August 07, 2017
  US FDA grants orphan drug status to Chondrial Therapeutics' CTI-1601 to treat Friedreich’s Ataxia,   August 05, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |